- Home
- KPLT vs LUCD Comparison
KPLT vs LUCD Comparison
Compare KPLT & LUCD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KPLT
- LUCD
- Stock Information
- Founded
- KPLT 2012
- LUCD 2018
- Country
- KPLT United States
- LUCD United States
- Employees
- KPLT N/A
- LUCD N/A
- Industry
- KPLT Diversified Commercial Services
- LUCD Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- KPLT Consumer Discretionary
- LUCD Health Care
- Exchange
- KPLT Nasdaq
- LUCD Nasdaq
- Market Cap
- KPLT 35.6M
- LUCD 140.7M
- IPO Year
- KPLT N/A
- LUCD 2021
- Fundamental
- Price
- KPLT $8.07
- LUCD $1.16
- Analyst Decision
- KPLT Hold
- LUCD Strong Buy
- Analyst Count
- KPLT 2
- LUCD 4
- Target Price
- KPLT $12.00
- LUCD $3.94
- AVG Volume (30 Days)
- KPLT 25.1K
- LUCD 1.5M
- Earning Date
- KPLT 08-13-2025
- LUCD 08-11-2025
- Dividend Yield
- KPLT N/A
- LUCD N/A
- EPS Growth
- KPLT N/A
- LUCD N/A
- EPS
- KPLT N/A
- LUCD N/A
- Revenue
- KPLT $254,079,000.00
- LUCD $4,173,000.00
- Revenue This Year
- KPLT $22.26
- LUCD $91.46
- Revenue Next Year
- KPLT $11.03
- LUCD $213.42
- P/E Ratio
- KPLT N/A
- LUCD N/A
- Revenue Growth
- KPLT 9.72
- LUCD 39.89
- 52 Week Low
- KPLT $5.08
- LUCD $0.72
- 52 Week High
- KPLT $21.88
- LUCD $1.80
- Technical
- Relative Strength Index (RSI)
- KPLT 43.54
- LUCD 42.03
- Support Level
- KPLT $7.37
- LUCD $1.13
- Resistance Level
- KPLT $10.09
- LUCD $1.21
- Average True Range (ATR)
- KPLT 0.88
- LUCD 0.07
- MACD
- KPLT -0.14
- LUCD -0.01
- Stochastic Oscillator
- KPLT 18.53
- LUCD 28.57
About KPLT Katapult Holdings Inc.
Katapult Holdings Inc. is a technology-driven lease-to-own platform that integrates with omni-channel retailers and e-commerce platforms to power the purchase of everyday durable goods for underserved U.S. non-prime consumers. It is an e-commerce-focused FinTech company offering a lease-purchase solution to consumers and enabling essential transactions at the merchant point of sale. Katapult is associated with hundreds of retailers across the United States.
About LUCD Lucid Diagnostics Inc.
Lucid Diagnostics Inc is a commercial-stage medical diagnostics technology company focused on the millions of patients with gastroesophageal reflux disease (GERD), also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically lethal esophageal adenocarcinoma. Its products include EsoCheck and EsoGuard.